Daiwa Securities Group Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 83 shares of MDGL stock, worth $25,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 74
12.16%
Holding current value
$25,121
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MDGL
# of Institutions
295Shares Held
22MCall Options Held
634KPut Options Held
428K-
Janus Henderson Group PLC London, X02.48MShares$750 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$618 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$614 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$603 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$598 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.18B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...